A clinical trial involving 44 US primary care practices and 11,980 patients was conducted to enhance follow-up on abnormal cancer screenings, focusing on breast, cervical, colorectal, and lung...
CURATED BY: Nina Grenon, DNP, AGCNP- BC, AOCN
Nina Grenon,
DNP, AGCNP- BC, AOCN
Dana-Farber Cancer Institute Center for Gastrointestinal Oncology
Machine Learning Identifies Risk Groups in Advanced Cancer Patients: Higher Pretreatment Severity Linked to Hospitalization and Mortality
Researchers of a study examined whether unsupervised machine learning, based on baseline patient-reported symptom severity, could help stratify older adults...
Nina Grenon,
DNP, AGCNP- BC, AOCN
Dana-Farber Cancer Institute Center for Gastrointestinal Oncology